Lisata Therapeutics Stock In The News
| LSTA Stock | USD 2.88 0.04 1.41% |
Our overall analysis of Lisata Therapeutics' news coverage and content from conventional and social sources shows investors' bearish mood towards Lisata Therapeutics. The specific impact of Lisata Therapeutics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Lisata Therapeutics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Lisata Therapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Lisata Therapeutics Backtesting and Lisata Therapeutics Hype Analysis. For information on how to trade Lisata Stock refer to our How to Trade Lisata Stock guide.
Lisata |
Lisata Therapeutics Today Top News and Investor Outlook
Lisata Therapeutics Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Lisata and other traded companies coverage with news coverage. We help investors stay connected with Lisata headlines for the 24th of November to make an informed investment decision based on correlating the impacts of news items on Lisata Stock performance. Please note that trading solely based on the Lisata Therapeutics hype is not for everyone as timely availability and quick action are needed to avoid losses.
Lisata Therapeutics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Lisata earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Lisata Therapeutics that are available to investors today. That information is available publicly through Lisata media outlets and privately through word of mouth or via Lisata internal channels. However, regardless of the origin, that massive amount of Lisata data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Lisata Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Lisata Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Lisata Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Lisata Therapeutics alpha.
Lisata Largest EPS Surprises
Earnings surprises can significantly impact Lisata Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-08-12 | 2024-06-30 | -0.76 | -0.61 | 0.15 | 19 | ||
2024-11-01 | 2024-09-30 | -0.77 | -0.59 | 0.18 | 23 | ||
2023-08-14 | 2023-06-30 | -0.7 | -0.5 | 0.2 | 28 | ||
2022-08-04 | 2022-06-30 | -1.45 | -1.65 | -0.2 | 13 | ||
2024-02-29 | 2023-12-31 | -0.89 | -0.66 | 0.23 | 25 | ||
2023-03-30 | 2022-12-31 | -1.01 | -0.76 | 0.25 | 24 |
Lisata Therapeutics Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Lisata Therapeutics Stock. Current markets are strongly bullish. About 86% of major world exchanges and indexes are currently up. See today's market update for more information.
21st of November 2024
The Dr. James Morales Grant for Medicine and Biosciences Invites Undergraduate Scholars to... at finance.yahoo.com
20th of November 2024
Forte Biosciences, Inc. Announces Oversubscribed 53 Million Private Placement From Leading... at gurufocus.com
19th of November 2024
Alamar Biosciences Announces Collaboration with The Michael J. Fox Foundation to Advance P... at kalkinemedia.com
18th of November 2024
Arcadia Biosciences Q3 Earnings Miss Estimates, Sales Increase YY at finance.yahoo.com
15th of November 2024
Willow Biosciences Third Quarter 2024 Earnings CA0.01 loss per share at finance.yahoo.com
14th of November 2024
Akoya Biosciences Reports Third Quarter 2024 Financial Results at finance.yahoo.com
8th of November 2024
Castle Biosciences Is a Great Choice for Trend Investors, Heres Why at finance.yahoo.com
31st of October 2024
Harmony Biosciences Holdings, Inc. Just Recorded A 19 percent EPS Beat Heres What Analysts... at simplywall.st
24th of October 2024
Brixton Biosciences Receives 2M NIH HEAL Initiative Grant to Drive Drug-Free Pain Relief I... at finance.yahoo.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Lisata Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Lisata Therapeutics' short interest history, or implied volatility extrapolated from Lisata Therapeutics options trading.
Check out Lisata Therapeutics Backtesting and Lisata Therapeutics Hype Analysis. For information on how to trade Lisata Stock refer to our How to Trade Lisata Stock guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lisata Therapeutics. If investors know Lisata will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lisata Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.51) | Return On Assets (0.29) | Return On Equity (0.44) |
The market value of Lisata Therapeutics is measured differently than its book value, which is the value of Lisata that is recorded on the company's balance sheet. Investors also form their own opinion of Lisata Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Lisata Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lisata Therapeutics' market value can be influenced by many factors that don't directly affect Lisata Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lisata Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Lisata Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lisata Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.